Speakers

Nancy Meyerson-Hess


Chief Compliance and Regulatory Officer - eMQT





Nancy Meyerson-Hess

Sessions


  • Tuesday - May 28, 2024 - 08:50

    Welcome Address & Chairperson’s opening remarks

    Begin your conference journey with a warm welcome from our esteemed Chairperson


  • Tuesday - May 28, 2024 - 14:30

    Panel discussion: Critical Success Factors while Planning for Site Selection and Patient Recruitment

    • Discover sites with a demonstrated track record of good execution in trials
    • Study and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.
    • Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be considered.
    • Access to subject population with the required eligibility criteria
    • Network within industries


  • Tuesday - May 28, 2024 - 16:50

    Panel Discussion: The Future of Patient-Centricity in Clinical Trials - Embedding a patient-centric approach to clinical trial design

    • How to integrate patient feedback into clinical trial design effectively.
    • The role of digital health technologies in enhancing patient engagement and experience.
    • Strategies for maintaining communication and trust with participants throughout the trial.
    • The impact of patient-centric approaches on trial outcomes and drug development timelines.
    • Ethical considerations and data privacy in a patient-centered model.


  • Wednesday - May 29, 2024 - 08:50

    Welcome Address & Chairperson’s opening remarks

    Start the second day with insightful remarks from our Chairperson


  • Wednesday - May 29, 2024 - 13:30

    Panel Discussion: Leveraging Big Data and AI in the Era of Tech-Driven Clinical Trials: Opportunities and Ethical Dilemmas


  • Wednesday - May 29, 2024 - 17:20

    Panel Discussion – Breaking Silos, Building Bridges: Fostering Collaborative Ecosystems in Clinical Research

    • Exploring the dynamics and benefits of partnerships between biotech firms, pharma, academia, and healthcare providers.
    • Strategies for involving patients and the public in the research process to ensure studies are aligned with patient needs and societal expectations.
    • The importance of collaboration in conducting large-scale, multi-national trials, especially in the face of global health crises.
    • The need for regulatory agencies to work together to streamline approval processes while ensuring patient safety.


 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now